Product Images Topiramate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Topiramate NDC 50436-1220 by Unit Dose Services, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
cb6f6b8d f5f3 4839 be54 dc2932ff649e 01
cb6f6b8d f5f3 4839 be54 dc2932ff649e 02
This appears to be a graph or chart showing cumulative rates over time for an unknown variable. The y-axis values are 0.00 to 0.30 and the x-axis ranges from 100 to 450. The value "p = 0.0002" may indicate a statistical significance level. More information would be needed to provide a more precise description of the graph's content and context.*
cb6f6b8d f5f3 4839 be54 dc2932ff649e 03
The text states the change in the average monthly migraine period rate after the double-blind phase while taking Topamax at a dosage of either 100 or 200 milligrams per day. It also includes statistical significance with p-values.*
Label Image - lbl504361220
This is a description of the medication named Topiramate. It is a 25mg/30 tablet strength medication that is manufactured by Cipla Ltd., in Kurkumbh, India. The tablets contain Topisrat USP 25g. The tablets should be dispensed in a tight container as defined in the USP and kept away from children, stored at a temperature range of 20-35 °C. The lot number for this medication is indicated as XXXXXX. The package insert contains dosage information, and this medication is only available with a prescription.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.